Last updated on January 2019

A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder


Brief description of study

To Demonstrate the Efficacy of Brexpiprazole for the Acute Treatment of Manic Episodes, With or Without Mixed Features, in Subjects with a Diagnosis of Bipolar I Disorder

Detailed Study Description

A multicenter, randomized, double-blind trial of Brexpiprazole versus Placebo for the acute treatment of manic episodes, with or without mixed features, associated with bipolar I disorder. This study will also demonstrate the safety and tolerability of brexpiprazole in the study population of males and females aged 18 to 65 years (inclusive, at time of consent).

Clinical Study Identifier: NCT03259555

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.